a public good project by the
Synthesis
Company
of California

© 2026

Norman Gitlin | doi.page

0 works0 citations0 h-index

Norman Gitlin

Publications by Year

Research Areas

Liver Disease Diagnosis and Treatment, Hepatitis C virus research, Liver Disease and Transplantation, Hepatitis B Virus Studies, Liver Diseases and Immunity

Most-Cited Works

→ Ledipasvir and Sofosbuvir for Untreated HCV Genotype 1 Infection(2014)1,699 cited
→ Ledipasvir and Sofosbuvir for Previously Treated HCV Genotype 1 Infection(2014)1,302 cited
→ Simeprevir plus sofosbuvir, with or without ribavirin, to treat chronic infection with hepatitis C virus genotype 1 in non-responders to pegylated interferon and ribavirin and treatment-naive patients: the COSMOS randomised study(2014)814 cited
→ All‐oral 12‐week treatment with daclatasvir plus sofosbuvir in patients with hepatitis C virus genotype 3 infection: ALLY‐3 phase III study(2015)688 cited
→ Peginterferon alfa-2a (40 kilodaltons) and ribavirin in patients with chronic hepatitis C and normal aminotransferase levels(2004)244 cited
→ Two Cases of Severe Clinical and Histologic Hepatotoxicity Associated with Troglitazone(1998)230 cited

→ The diagnosis and prevalence of subclinical hepatic encephalopathy in apparently healthy, ambulant, non-shunted patients with cirrhosis(1986)

210 cited

→ Extended lamivudine retreatment for chronic hepatitis B: Maintenance of viral suppression after discontinuation of therapy(1999)196 cited

→ Simeprevir plus sofosbuvir (12 and 8 weeks) in hepatitis C virus genotype 1‐infected patients without cirrhosis: OPTIMIST‐1, a phase 3, randomized study(2016)189 cited

→ Seladelpar (MBX-8025), a selective PPAR-δ agonist, in patients with primary biliary cholangitis with an inadequate response to ursodeoxycholic acid: a double-blind, randomised, placebo-controlled, phase 2, proof-of-concept study(2017)182 cited